Fingerprint
Dive into the research topics of 'Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non-Hodgkin's lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically